Yposkesi, an SK pharmteco company

Yposkesi, an SK pharmteco company, is one of Europe's largest CDMO's for clinical and commercial viral vector manufacturing #genetherapy 🧪#raredisease #AAV

[La Semaine de l'Île-de-France @semaine_idf]

🔬 Plan #France2030, l'@AgenceRecherche labellise "Biocluster" #Genother, un projet d'excellence en thérapie génique.
🧬Genother, un projet fondé par @GenethonFr @Genopole @APHP @Inserm @iGEM_Evry @spark_tx @yposkesi
https://t.co/VxesdVrPjG

#scientifique #essonne #label

[AMPAC Analytical - An SK pharmteco Company @AMPACAnalytical]

Our @Marc90274 is attending the #ASGCT23 annual meeting and has met many old & new friends, including some at our sister company, @yposkesi! Stop by, say hello & learn how we can assist with your elemental impurities.
https://t.co/Z5nMSV6zyd
https://t.co/jRWcwgt6fP
#CGT

[LAMBE @_LAMBE_]

Le laboratoire LAMBE @INC_CNRS au sein du campus évryen et génopolitain se réjouit de la labellisation #France2030 et du succès du biocluster Genother et félicite ses fondateurs @GenethonFr, @UnivEvry, @APHP, @Inserm, @SparkTherapeutics, @yposkesi, @Genopole

@UnivParisSaclay

[Roland Lescure @RolandLescure]

La France a été l’un des berceaux de la thérapie génique.

Inauguration avec @BrunoLeMaire de la nouvelle usine d’@yposkesi, spécialisée dans ces thérapies. Un enjeu d’attractivité pour la France, de souveraineté sanitaire et d’accès aux médicaments innovants pour les patients.

[Laure Darcos @LDarcos]

Ce matin aux côtés de @beaudetstephane et Gilles Trystram, Président et Directeur du @Genopole, pour la visite du nouveau site de bioproduction d’@yposkesi des Ministres @BrunoLeMaire et @RolandLescure 🇫🇷

Très fière d’avoir cette pépite biotechnologique en Essonne !

[Yposkesi, an SK pharmteco company @yposkesi]

🎙 Listen to our last podcast in collaboration with @PallCorporation, published by @Bio_Insights.

In this new piece, experts are discussing the Improvement of #ViralVector #purification using Mustang Q membrane #chromatography.

Link to the podcast: https://t.co/DwSe6dpWRb

[Yposkesi, an SK pharmteco company @yposkesi]

Meet the @Yposkesi team at the World Oncology Cell Therapy Congress today!

#ViralVector #CDMO #WOCTCongress

[Yposkesi, an SK pharmteco company @yposkesi]

Today is #DNAday! 🧬

We are celebrating the 70th anniversary of the discovery of the DNA double helix and the 20th anniversary of the Human Genome Project’s completion!

#CDMO #ViralVector #Manufacturing

[Yposkesi, an SK pharmteco company @yposkesi]

If you are in Barcelona this week for #CGMed23 and are interested in #ViralVector #Manufacturing, book a meeting with the Yposkesi team: https://t.co/tinfrCZxnO

The team will happily discuss our manufacturing capabilities and our new #Lentiviral vector platform, LentiSure™.

[Andrew Lloyd ALA @ALA_Group]

[ALA Client News] @Yposkesi launches LentiSure™, Lentiviral (LV) Vector production platform optimized for higher yields

https://t.co/qRjMKzCFqT

#cellandgenetherapy #immunooncology #CDMO

[Yposkesi, an SK pharmteco company @yposkesi]

🎉NEW! LentiSure™: Plug & Play Robust and Scalable, Lentivirus Manufacturing Platform!

Launching today, our new platform gives you access to a #TimeEfficient and #CostEffective streamlined environment.

More: https://t.co/WM8YIiuL4j

[Yposkesi, an SK pharmteco company @yposkesi]

The Yposkesi team is attending #CGMed23 next week in Barcelona!
Interested in learning more about our #ViralVector #Manufacturing capabilities? Book a meeting with the team!

[Yposkesi, an SK pharmteco company @yposkesi]

Meet us in Tours! During the next @Polepharma Bioproduction conference, meet our team to discuss #ViralVectorManufacturing.

📣 April 5 at 16h35, Cédrick will participate in “The challenges of innovation in bioproduction. How to accelerate the processes of tomorrow?” roundtable!

[Yposkesi, an SK pharmteco company @yposkesi]

📣 We are hiring!

Process Validation Lead, #CMC Project Manager, #Quality Assurance Lead and other! Several #positions are currently open at Yposkesi, browse our careers page to learn more and apply today! 👨‍🔬🧬

Mode details: https://t.co/8W4asoZUZH

[Yposkesi, an SK pharmteco company @yposkesi]

#BioProcess Development is a crucial part of any #biopharmaceutical, whether it is an #ATPM or not. In our recent article, learn more about BioProcess Development and how it can help your clinical trials and commercialization.

Link to the article: https://t.co/AbQWXCRkFn

[Yposkesi, an SK pharmteco company @yposkesi]

La semaine prochaine, ne manquez pas notre #webinar en partenariat avec @Polepharma et @aktehom : "L'approche Analytical Quality by Design".

📅 16 mars 2023
⏰ 9h30 CET

🧾 Inscription: https://t.co/rOZ5f1bS3Q

#AQbD #CDMO #Analytics

[Yposkesi, an SK pharmteco company @yposkesi]

Today is #RareDiseaseDay!
Did you know that 300 million people worldwide live with a rare disease and 72% of rare diseases are genetic? Today brings awareness to those persons living with a rare disease and the clinical development of curative therapies. #shareyourcolours

[Yposkesi, an SK pharmteco company @yposkesi]

Meet our team at #CARTCREurope!

[Yposkesi, an SK pharmteco company @yposkesi]

☀ Will you be in sunny San Diego next week? Yposkesi will be there attending the Next Gen CAR & T Cell Therapies, part of #BPIWest.

Interested in #ViralVector manufacturing? make sure to stop by booth #322 to discuss your project(s) 🧬👨‍🔬.

More info: https://t.co/UPxhGMVCRI

[Yposkesi, an SK pharmteco company @yposkesi]

Yposkesi will be attending @CAR_TCell next week in #London. If you are interested in #ViralVector manufacturing, stop by booth #29 to meet with Christophe and Marie. They will be happy to discuss your project 🧬👨‍🔬.

https://t.co/jkufrm5OCR

#CDMO #Manufacturing #Conference